Division of Colorectal surgery

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Robotics 89%
3. Rectal Neoplasms 58%
4. Laparoscopy 37%
5. nano-diamino-tetrac 32%
6. Neoplasm Metastasis 32%
7. Colorectal Surgery 32%
8. Colonic Neoplasms 30%
9. Transanal Endoscopic Surgery 25%
10. Learning Curve 24%
11. Margins of Excision 22%
12. Hemorrhoidectomy 22%
13. Neoplasms 21%
14. Autophagy 20%
15. Catenins 19%
16. glucose-regulated proteins 19%
17. Gefitinib 17%
18. Oxaliplatin 17%
19. Meta-Analysis 17%
20. Hepatocellular Carcinoma 17%
21. Ergonomics 17%
22. Therapeutics 16%
23. Surgeons 15%
24. heteronemin 15%
25. Systematic Reviews 15%
26. Hemorrhoids 15%
27. ovatodiolide 15%
28. Down-Regulation 15%
29. tetraiodothyroacetic acid 14%
30. Phosphatidylinositol 3-Kinases 14%
31. Nicotine 14%
32. gamma-mangostin 14%
33. Neoplastic Stem Cells 14%
34. 3-ingenyl angelate 12%
35. alpha7 Nicotinic Acetylcholine Receptor 12%
36. Propyl Gallate 12%
37. MicroRNAs 12%
38. Length of Stay 12%
39. Garcinia mangostana 11%
40. Anal Canal Carcinoma 11%
41. S100 Calcium-Binding Protein A4 11%
42. Stromal Interaction Molecule 1 11%
43. Anecdotes 11%
44. Bromelains 11%
45. Cancer-Associated Fibroblasts 10%
46. HCT116 Cells 10%
47. Areca 10%
48. Drug Therapy 10%
49. Randomized Controlled Trials 10%
50. HSP27 Heat-Shock Proteins 10%
51. Computational Biology 10%
52. Population 9%
53. Defensins 9%
54. Heterografts 9%
55. Adenomatous Polyps 9%
56. Network Meta-Analysis 9%
57. Pedestrians 9%
58. Exosomes 9%
59. Aldehyde Dehydrogenase 9%
60. Sulfasalazine 9%
61. Uracil 9%
62. HT29 Cells 9%
63. Occult Blood 9%
64. Odds Ratio 9%
65. Reoperation 9%
66. Nuts 9%
67. Chemoradiotherapy 8%
68. Circulating Neoplastic Cells 8%
69. Therapeutic Index 8%
70. Fecal Incontinence 8%
71. Survivin 8%
72. Appendectomy 8%
73. Lipoma 8%
74. Cell Movement 8%
75. Fluorouracil 8%
76. Curcumin 8%
77. Minimally Invasive Surgical Procedures 8%
78. ErbB Receptors 8%
79. Colon 8%
80. Colectomy 7%
81. Amphotericin B 7%
82. Nicotinic Receptors 7%
83. Liver 7%
84. Growth 7%
85. Hand Strength 7%
86. Osteosarcoma 7%
87. Septic Shock 7%
88. Up-Regulation 7%
89. Carcinogenesis 7%
90. Radiotherapy 7%
91. Epidermal Growth Factor 7%
92. Taiwan 6%
93. Geriatrics 6%
94. Estrogen Receptors 6%
95. Genes 6%
96. Cross-Over Studies 6%
97. Recurrence 6%
98. Stomach Neoplasms 6%
99. Safety 6%